PRINCIPLES OF TREATMENT OF A PATIENT WITH ACUTE LUMBAR PAIN


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Lumbar pain (LP) is one of the main causes of temporary disability and a decline in the quality of life. Modern approaches to the management of patients with LP, including pharmacotherapy and nondrug therapies, are considered. The advantages and disadvantages of the main groups of drugs used to treat such patients are discussed. From the standpoint of evidence-based medicine, the question of choosing the optimal therapeutic tactics is analyzed, which makes it possible to reduce the likelihood of unwanted side effects.

全文:

受限制的访问

作者简介

Pavel Kamchatnov

N.I. Pirogov Russian National Research Medical University

Email: pavkam7@gmail.com
MD, professor of the Department of neurology, neurosurgery and medical genetics 117997, Moscow, 1 Ostrovityanova St

Mikhail Yevzel'man

I.S. Turgenev Orel State University

MD, professor of the Department of psychiatry and neurology, Medical faculty 302028, Orel, 25 Oktyabrskaya St

Aleksandr Chugunov

N.I. Pirogov Russian National Research Medical University

PhD, professor of the Department of neurology, neurosurgery and medical genetics 117997, Moscow, 1 Ostrovityanova St

参考

  1. CDC. National Ambulatory Medical Care Survey: 2010 Summary Tables. Table 9. www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_ namcs_web_tables.pdf. Accessed March 29, 2016.
  2. Vos T., Flaxman A., Naghavi M. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163-96.
  3. Hoy D., March L., Brooks P., Blyth F., Woolf A., Bain C., Williams G., Smith E., Vos T., Barendregt J., Murray C., Burstein R., Buchbinder R. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann. Rheum. Dis. 2014;73:968-74.
  4. Есин Р.Г., Есин О.Р., Ахмадеева Г.Д., Салихова Г.В. Боль в спине. Казань: Казанский полиграфкомбинат, 2010. 272 с. [Yesin R.G., Yesin O.R., Akhmadeeva G.D., Salikhova G.V. Back pain. Kazan: Kazan polygraphkombinat, 2010. 272 p.]
  5. Katz J. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J. Bone Joint Surg. Am. 2006;88 (Suppl. 2):21-8.
  6. Mafi J., McCarthy E., Davis R., Landon B. Worsening trends in the management and treatment of back pain. JAMA Intern. Med. 2013;173(17):1573-81.
  7. Sivasubramaniam V., Patel H., Ozdemir B. et al. Trends in hospital admissions and surgical procedures for degenerative lumbar spine disease in England: a 15-year time series study. BMJ Open. 2015;5:e009011.
  8. Wong J., Cote P., Sutton D., Randhawa K., Yu H., Varatharajan S., Goldgrub R., Nordin M., Gross D.P., Shearer H.M., Carroll L.J., Stern P.J., Ameis A., Southerst D., Mior S., Stupar M., Varatharajan T., Taylor-Vaisey A. Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur. J. Pain. 2017;21(2):201-16.
  9. Cutforth G., Peter A., Taenzer P. The Alberta health technology assessment (HTA) ambassador program: The development of a contextually relevant, multidisciplinary clinical practice guideline for non-specific low back pain: A review. Physiother. Can. 2011;63:278-86.
  10. van Middelkoop M., Rubinstein S., Verhagen A., Ostelo R.W., Koes B.W., van Tulder M.W. Exercise therapy for chronic nonspecific low-back pain. Best Pract. Res. Clin. Rheumatol. 2010;24(2):193-204.
  11. Miyamoto G., Costa L., Galvanin T., Cabral C. Efficacy of the addition of modified Pilates exercises to a minimal intervention in patients with chronic low back pain: a randomized controlled trial. Phys Ther. 2013;93(3):310-20.
  12. Livingston C., King V., Little A. et al. Evidence-based clinical guidelines project. evaluation and management of low back pain: A clinical practice guideline based on the joint practice guideline of the American College of Physicians and the American Pain Society. Salem, Oregon: Office for Oregon Health Policy and Research. 2011.
  13. Баранцевич Е. Р., Андреев В.В. Возможности лечения хронической боли при пояснично-крестцовой радикулопатии. Врач. 2012;11:13-9.
  14. Emilson C., Demmelmaier I., Bergman S., Lindberg P., Denison E., Asenlöf P. A 10-year follow-up of tailored behavioural treatment and exercise-based physiotherapy for persistent musculoskeletal pain. Clin. Rehabil. 2017;31(2):186-96.
  15. Werner E., Storheim K., Lochting I. et al. Cognitive patient education for low back pain in primary care: A cluster randomized controlled trial and cost-effectiveness analysis. Spine (Phila Pa 1976). 2016;41(6):455-62.
  16. Chou R., Qaseem A., Snow V., Casey D., Cross J.T. Jr, Shekelle P., Owens D.K. Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann. Intern. Med. 2007;147:478-91.
  17. Roberts E., Nunes V., Buckner S., Latchem S., Constanti M., Miller P., Doherty M., Zhang W., Birrell F., Porcheret M., Dziedzic K., Bernstein I., Wise E., Conaghan P.G. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann. Rheum. Dis. 2016;75:552-9.
  18. Saragiotto B., Machado G., Ferreira M., Pinheiro M.B., Abdel Shaheed C., Maher C.G. Paracetamol for low back pain. Cochrane Database Syst. Rev. 2016;(6):CD012230.
  19. Enthoven W., Roelofs P., Koes B. NSAIDs for chronic low back pain. JAMA. 2017;317(22):2327-8.
  20. Roelofs P., Deyo R., Koes B., Scholten R.J., van Tulder M.W. Nonsteroidal anti-inflammatory drugs for low back pain. An Updated Cochrane Review. Spine. 2008;16(33):1766-74.
  21. Lin J., Zhang W., Jones A., Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ. 2004;329:324-8.
  22. Насонов Е.Л., Яхно Н.Н., Каратеев А.Е., Алексеева Л.И., Баринов А.Н., Барулин А.Е., Давыдов О.С., Данилов А.Б., Журавлева М.В., Заводовский Б.В., Копенкин С.С., Кукушкин М.Л., Парфенов В.А., Страхов М.А., Тюрин В.П., Чичасова Н.В., Чорбинская С.А. Общие принципы лечения скелетно-мышечной боли: междисциплинарный консенсус. Научно-практическая ревматология. 2016;3(54):247-65
  23. Goldstein J., Cryer B. Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies. Drug. Healthcare and Patient Safety. 2015;7:31-41.
  24. Figueiras A., Estany-Gestal A., Aguirre C., Ruiz B., Vidal X., Carvajal A., Salado I., Salgado-Barreira A., Rodella L., Moretti U., Ibanez L. EMPHOGEN group. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study. Pharmacogenet. Genomics. 2016;26(2):66-73.
  25. Moodley I. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovascular J. Afr. 2008;19(2):102-7.
  26. Nissen S., Yeomans N., Solomon D., Lüscher T.F., Libby P., Husni M.E., Graham D.Y., Borer J.S., Wisniewski L.M., Wolski K.E., Wang Q., Menon V., Ruschitzka F., Gaffney M., Beckerman B., Berger M.F., Bao W., Lincoff A.M. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N. Engl. J. Med. 2016;375(26):2519-29.
  27. Dequeker J., Hawkey C., Kahan A. et al. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis. Br. J. Rheumatol. 1998;37(9):946-51.
  28. Hawkey C., Kahan A., Steinbrück K. et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam large-scale international study safety assessment. Br. J. Rheumatol. 1998;37(9):937-45.
  29. Riou B., Plaisance P., Lecomte F. Comparison of two doses of ketoprofen to treat pain: a double-blind, randomized, noninferiority trial. Fundam. Clin. Pharmacol. 2014;28(1):20-8.
  30. Secoli S., Padilha K., Litvoc J. Cost-effectiveness analysis of the analgesic therapy of postoperative pain. Rev. Lat. Am. Enfermagem. 2008;16(1):42-6.
  31. Barden J., Derry S., McQuay H., Moore R. Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst. Rev. 2009;(4):CD007355.
  32. Федин А.И., Батышева Т.Т., Винецкий Я.Я., Козлов М.Ю. Кетонал в лечении острых дорсалгий. Лечение нервных болезней. 2002;2(7):27-9.
  33. Lapi F., Piccinni C., Simonetti M., Levi M., Lora Aprile P., Cricelli I., Cricelli C., Fanelli A. Non-steroidal anti-inflammatory drugs and risk of cerebrovascular events in patients with osteoarthritis: a nested case-control study. Intern. Emerg. Med. 2016;11(1):49-59.
  34. Agundez J., Lucena M., Martinez C., Andrade R.J., Blanca M., Ayuso P., Garcia-Martin E. Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Expert. Opin. Drug. Metab. Toxicol. 2011;7(7):817-28.
  35. Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World. J. Gastroenterol. 2010;16(45):5651-61.
  36. Schmeltzer P., Kosinski A., Kleiner D.E., Hoofnagle J.H., Stolz A., Fontana R.J., Russo M.W. Drug-Induced Liver Injury Network (DILIN). Liver injury from nonsteroidal anti-inflammatory drugs in the United States. Liver Int. 2016;36(4):603-9.
  37. Brattwall M., Turan I., Jakobsson J. Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review. J. Pain Res. 2010;3:131-5.
  38. Gouveia N., Rodrigues A., Ramiro S., Eusébio M., Machado P.M., Canhäo H., Branco J.C. The use of analgesic and other pain-relief drugs to manage chronic low back pain: results from a National Survey. Pain Practice. 2017;7(3):353-65.
  39. van Tulder M., Becker A., Bekkering T., Breen A., del Real M.T., Hutchinson A., Koes B., Laerum E., Malmivaara A. COST B Working Group on Guidelines for the Management of Acute Low Back Pain in Primary Care. Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care. Eur. Spine J. 2006;15 (Suppl. 2):S169-91.
  40. Qaseem A., Wilt T., McLean R., Forciea M.A. Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 2017;166(7):514-30.
  41. Mueller-Schwefe G. Flupirtine in acute and chronic pain associated with muscle tenseness. Results of a postmarket surveillance study. Fortschr. Med. Orig. 2003;121(1):11-8.
  42. Pareek A., Chandurkar N., Chandanwale A., Ambade R., Gupta A., Bartakke G. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. Eur. Spine J. 2009;18(12):1836-42.
  43. Mibielli M., Geller M., Cohen J. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr. Med. Res. Opin. 2009;25(11):2589-99.
  44. Vetter G., Bruggemann G., Lettko M. Shortening diclofenac therapy by B vitamins. Results of a randomized double-blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, in painful spinal diseases with degenerative changes. Z. Rheumatol. 1988;47(5):351-62.
  45. Batysheva T.T., Otcheskaya O.V., Kamchatnov P.R. et al. Efficacy of the combination of Arthrosan and Combilipen in patients with acute lower spinal pain. Neuroscience and Behavioral Physiology. 2013;43(2):240-3.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2017
##common.cookie##